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A B S T R A C T 
 
 
Introduction:  Faecal incontinence is the involuntary loss of liquid or solid stool with or without the patient’s awareness. It affects 
8–11% of Australian community dwelling adults and up to 72% of nursing home residents with symptoms causing embarrassment, 
loss of self-respect and possible withdrawal from normal daily activities. Biofeedback, a technique used to increase patient 
awareness of physiological processes not normally considered to be under voluntary control, is a safe, conservative first-line 
therapy that has been shown to reduce symptom severity and improve patient quality of life. The Townsville Hospital, a publicly 
funded regional hospital with a large rural catchment area, offers anorectal biofeedback for patients with faecal incontinence, 
constipation and chronic pelvic pain. The aim of this report is to describe the effect of the biofeedback treatment on the wellbeing 
of regional and rural participants in a study of biofeedback treatment for faecal incontinence in the Townsville Hospital clinic. 
Methods:  There were 53 regional (14 male) and 19 rural (5 male) participants (mean age 62.1 years) enrolled in a biofeedback 
study between January 2005 and October 2006. The program included 4 sessions one week apart, 4 weeks home practice of 
techniques learnt and a final follow-up reassessment session. Session one included documenting relevant history, diet, fibre, and 
fluid intake and treatment goals; anorectal function and proctometrographic measurements were assessed. Patients were taught 
relaxation (diaphragmatic) breathing in session two with a rectal probe and the balloon inserted, prior to inflating the balloon to 
sensory threshold. In session three, patients were taught anal sphincter and pelvic floor exercises linking the changes in anal 
pressures seen on the computer monitor with the exercises performed and sensations felt. Session four included improving anal and 
pelvic floor exercises, learning a defecation technique and receiving instructions for 4 weeks home practice. At the fifth session, 
home practice and bowel charts were reviewed and anorectal function was reassessed. Symptom severity and quality of life were 
assessed by surveying participants prior to sessions one and two and following session five. Patients were interviewed after session 
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five to determine their satisfaction with the therapy and the helpfulness of individual program components. They were mailed a 
follow-up survey 2 years later. 
Results:  Regional participants lived within 30 min drive of the clinic (median distance 8 km) while rural participants travelled up 
to 903 km (median 339 km, p<0.001) to attend the clinic. Faecal Incontinence risk factors were similar for rural and regional 
participants. Rural participants reported poorer general health (p=0.004) and their symptoms affected their lifestyle more 
negatively (p=0.028). Participants’ incontinence (p<0.001) and quality of life (p<0.001) improved significantly over the treatment 
period. Improvement for rural participants over the course of treatment was marginally better than that of regional participants, 
although not significantly. More than 97% of patients reported that the biofeedback program was very/extremely helpful and all 
participants attending the final session reported that they would advise a friend in a similar situation not to wait, but seek help 
immediately, with more than half specifically citing the biofeedback program. Two years later regional participants’ symptoms and 
quality of life continued to improve while rural participants’ quality of life had regressed to pre-treatment levels. 
Conclusions:  For equivalent long term improvement in faecal continence and quality of life to be achieved in both regional and 
rural participants, an additional follow-up session with the biofeedback therapist, ongoing local support provided by continence 
advisors, or both, should be investigated for rural patients. 
 
Key words:  Australia, biofeedback, faecal incontinence, holistic program, quality of life, regional, rural. 
 
 
 
Introduction 
 
Faecal incontinence (FI), the involuntary loss of liquid or 
solid stool with or without the patient’s awareness, may 
cause embarrassment, loss of self-respect, psychiatric 
disorders, and withdrawal from the community1. Little 
systematic research of this socially disabling condition has 
been conducted to determine either the true burden on 
individuals and communities or the results of treatment in 
northern Australia. 
 
Community prevalence of FI has been reported to range 
between 8% and 11% in South Australia and New South 
Wales2-4. Faecal incontinence is a leading reason for nursing 
home placement in Australia where up to 72% of residents 
have the condition5. In studies conducted at the Colorectal 
and Urogynaecology outpatient clinics of the Townsville 
Hospital (TTH) in North Queensland more than one in five 
patients reported FI1,6. 
 
Biofeedback is a safe, conservative first-line treatment for 
FI7. The Townsville Hospital, a publicly funded regional 
hospital with an extensive rural catchment area, operates a 
nurse-run holistic biofeedback program for patients with FI, 
constipation or pelvic pain8,9. 
 
A Cochrane review of biofeedback for the treatment of FI 
found no evidence that any method of biofeedback or pelvic 
floor exercises provided better outcomes than any other 
conservative treatment method10. Standard care including 
diary and symptom questionnaire, structured assessment, 
patient teaching, emotional support, lifestyle modifications, 
management of FI and urgency control was a method that 
provided equivalent results11. When telephone assisted 
support for remote patients was compared with face-to-face 
biofeedback protocol for regional patients, no significant 
outcome differences were found12. 
 
This clinical study was designed to assess two exercise 
regimens, the efficacy of biofeedback program components 
for FI (L Bartlett, K Sloots; unpubl. data, 2005–2006) and 
whether treatment outcomes (ie FI severity or quality of life 
[QOL]) differed between rural and regional participants. 
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Methods  
 
Participants 
 
Clinic patients were eligible to participate in the study if their FI 
had persisted for at least 6 months and had failed to respond to 
standard treatment recommended by their GP. Further eligibility 
criteria included being at least 18 years of age and not pregnant; 
and having no terminal illness, mental illness or gastrointestinal 
stoma. Participants were referred by a colorectal surgeon 
following anorectal physiologic assessment including manometry 
and endoanal ultrasound. They attended the biofeedback program 
between January 2005 and October 2006 and signed informed 
consent forms. 
 
Ethics 
 
Ethics approval was granted by Townsville Health Service 
District Human Research Ethics Committee (47/04) and 
James Cook University (H1950). The Australian New 
Zealand Clinical Trials Registry number is 
ACTRN12610000258055. 
 
Study procedure  
 
Faecal incontinence patients on the TTH biofeedback 
waitlist were initially telephoned, had the study explained to 
them and were invited to participate. An information pack 
about the study and biofeedback treatment with appointment 
dates and a bowel chart were mailed to them. Treatment 
included 5 outpatient sessions: 4 at weekly intervals, 4 weeks 
home practice of techniques learnt, then an assessment 
session. Detail of the study procedure is provided (Fig1). 
 
Participants met with the researcher immediately prior to the 
initial biofeedback session and completed a self administered FI 
questionnaire1, including the 29 question Fecal Incontinence 
Quality of Life Scale (FIQL) survey tool13. The researcher 
completed the Cleveland Clinic Florida Fecal Incontinence Score 
(CCF-FI)14 with them. Session one with the biofeedback therapist 
included documenting: relevant medical, surgical, obstetric and 
medication history; and bowel problems and habits. Diet, fibre, 
and fluid intake were discussed together with the aim of therapy 
and the establishment of treatment goals and instructions given to 
record food, fluid, supplement intake and medications used in the 
patient diary. Anorectal function and proctometrographic 
evaluation were assessed using clinic manometric 
equipment15,16. The therapist presented coping strategies and 
dietary advice8. The pre-treatment bowel chart was reviewed and 
comprehensive instructions were given to accurately record daily 
bowel accidents and toileted motions using the Bristol Stool Form 
Scale17. Immediately before session two, participants repeated the 
FIQL and CCF-FI with the researcher. The biofeedback therapist 
then reviewed the previous week’s diary and bowel chart with the 
patient noting the impact of any dietary or coping modifications 
used, before instructing each patient in slow relaxation 
(diaphragmatic) breathing. Patients had the rectal probe and the 
balloon inserted, prior to inflating the balloon to sensory 
threshold. Lying in the supine position with one hand lightly 
resting on the upper abdomen to monitor diaphragmatic 
movement and rate of breathing, each participant practiced 
relaxation breathing for 5–10 min. Visual biofeedback was 
provided from the clinic computer monitor with verbal feedback 
from the therapist to improve the technique9. Patients were 
instructed to practise relaxation breathing at home at least twice 
per day and complete the bowel chart for the following week. 
 
Before session three the biofeedback therapist was advised the 
exercise regimen to which the patient had been randomised; that 
is: standard exercises (sustained pelvic floor and anal squeeze 
exercises) or alternative exercises (rapid and sustained pelvic 
floor and anal squeeze exercises)18. 
 
In session three the previous sessions’ therapy components 
were reviewed and amended. Anal sphincter and pelvic floor 
muscle exercises were taught according to the relevant 
exercise regimen. Participants were coached to link the 
changes in pressures seen on the computer monitor with the 
exercises performed and sensations felt. The aims of the 
exercises and techniques were to reduce urgency and 
frequency, and to improve sensitivity, anorectal co-
ordination and continence. Patients were asked to perform 
their individual prescribed exercises at home (Fig2). 
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Figure 1:  Participants’ progress through the study 
Assessed for eligibility (n = 101) 
Excluded (n = 29) 
Did not meet inclusion criteria (n = 2) 
Refused to participate (n = 1) 
Other reasons (n = 26 unable to contact) 
72 patients consented to participate; completed self administered questionnaire including FIQL and were 
asked continence score questions by an independent researcher prior to session 1 
Session 1:  Full history; Anorectal manometry & Proctometrography; Disclosure / Counselling; Instruction 
on completing bowel chart; Advice on diet & coping strategies 
72 completed FIQL and CCF-FI surveys with researcher prior to session 2 on 2nd attendance
 
day 
Session 4: RPS&PD; AS & PF exercises using biofeedback; Defecation technique 
Session 3:  RPS&PD, Anal sphincter (AS) & Pelvic floor (PF) exercises using biofeedback 
Session 5:  RPS&PD; review exercises using biofeedback & further instruction for ongoing home practice; 
Anorectal manometry & Proctometrography. 
FIQL, CCF-FI, satisfaction surveys and final interview with researcher 
Lost to follow up (n = 0); Discontinued 
intervention (n = 2); #54 failed to attend final 
session; minor FI & learnt techniques in 1st 4 
sessions; #61 found treatment did not work & 
caused pain. Analysed (n = 35) 
Follow-up survey in February 2008: CCF-FI & FIQL plus questions relating to current performance of 
anal sphincter and pelvic floor muscle exercises; type and number of bowel motions per day; other 
treatments for FI since the biofeedback therapy; changes to diet and medications since biofeedback therapy 
and their effect on FI 
Lost to follow up (n = 0); Discontinued 
intervention (n = 1); #44 failed to attend final 
session, has ongoing FI at 2 years and wants 
follow-up appointment 
Analysed (n = 34) 
En
ro
lm
en
t 
A
llo
ca
tio
n
 
Fo
llo
w
-
u
p 
A
n
a
ly
sis
 
Lost to follow-up (n = 6: 2 deceased, 4 
moved/uncontactable) 
Analysed (n = 28) 
Excluded from analysis: n = 9 
Discontinued treatment (n = 2) 
Lost to follow-up (n=6: #’s-11, 14, 38, 49, 59, 
68) 
Survey incomplete (n = 1: #32) 
Lost to follow up (n = 7: 1 deceased, 6 
moved/uncontactable) 
Analysed (n = 25) 
Excluded from analysis: n = 10 
Discontinued treatment (n = 1) 
Lost to follow-up (n = 7: #’s -7, 17, 19, 23, 
26, 52, 71) 
Survey incomplete (n=2: #2, #30) 
Session 2:  Review prior session & patient diary (RPS&PD); Relaxation Breathing 
Allocated to standard exercise regime: 
sustained squeezes only. (n = 37; 12 male) 
Allocated to Sustained + Rapid Squeeze 
regime (n = 35; 7 male) 
4 Weeks Home Practice 
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Figure 2:  Rapid and sustained anal sphincter squeeze instruction. 
 
 
A review of all components of previous treatment sessions 
(bowel charts, exercises, monitoring of dietary, medication, 
and fluid or supplement changes) was conducted by the 
biofeedback therapist in session four. The number and 
strength of prescribed exercises was increased as appropriate 
for the individual. A defecation technique, using a 
combination of the toileting position, relaxation breathing 
and evacuation technique was taught to assist with stool 
fragmentation and incomplete evacuation. Participants were 
then given written and verbal instructions on all components 
for their 4 week home practice. 
 
At the fifth session, patients’ home practice and bowel charts 
were reviewed with the biofeedback therapist; anorectal 
function was reassessed, and suggestions made for future 
improvements. Patients who felt they needed further support 
were able to book a follow-up appointment. At the 
completion of the fifth session the researcher reassessed 
severity of symptoms, the effect of FI on QOL and 
satisfaction with treatment outcomes; and also conducted a 
short semi structured interview to elicit participants’ 
opinions about: the reasons for the delay in seeking 
treatment for FI; advice they would give fellow FI sufferers; 
suggestions they could provide to improve FI disclosure; and 
usefulness of a home biofeedback device. 
In February 2008 all participants were mailed a follow-up 
survey. 
 
Statistical analysis  
 
Data were analysed on an intention-to-treat basis and 
patients who failed to complete the program were treated as 
missing.  Numerical data are given as mean value and 
standard deviation (SD) or median value and interquartile 
range (IQR), depending on the distribution. Comparisons 
between characteristics were undertaken using χ² tests and 
χ² tests for trend, non-parametric Wilcoxon tests, and t-
tests. Statistical analyses were conducted using SPSS for 
Windows v17 (SPSS Inc; Chicago, IL, USA; 
www.spss.com). Throughout the analyses p<0.05 was 
considered statistically significant. 
 
Results 
 
Participants  
 
Of 101 consecutive patients with FI referred for biofeedback, 
72 participants (19 male), mean age 62.1 years (95%CI 
38.3–85.9), were both eligible and consented to 
participate. Twenty participants (6 male) had previously 
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undergone bowel surgery, 12 for colorectal cancer 
(5 male). The surgery performed on these participants was: 
anterior resection, 11 (9 for low rectal carcinoma, 1 for 
diverticulitis, 1 for prolapse); segmental colectomy, 5 
(carcinoma 1; diverticulitis 2; ischaemia of colon 1; rectal 
prolapse 1); and total proctocolectomy with ileal J-pouch 
anastomosis, 4 (carcinoma 2; diverticulitis 1; constipation 1). 
Eight participants (4 male) reported difficulty with rectal 
emptying. Of the 53 female patients, 38 (72%) had external 
anal sphincter defects; 13 had been surgically repaired prior 
to biofeedback referral, 26 had difficult vaginal deliveries 
requiring forceps or vacuum extraction, 5 women had 
vaginal repair surgery only and 10 women had both vaginal 
repair surgery and difficult vaginal deliveries. Fifty-three 
participants (14 male) lived within 30 min drive of the clinic 
(median 7.8 km, IQR: 5.7–12.0) while 19 (5 male) travelled 
up to 903 km (median 339 km, IQR: 136–388) from rural 
locations (p<0.001) to attend the clinic. Female participants 
were younger than male participants, and significantly so for 
regional residents (p=0.044, Table 1). Overall, participants 
had suffered from FI for a median duration of 24 months 
(IQR 18–48) with rural women reporting FI for a 
significantly shorter period before seeking treatment than 
their regional counterparts (p=0.034, Table 2). There were 
no adverse events as a result of treatment. 
 
Baseline data 
 
Pre-existing medical conditions and prior surgical history 
known to be risk factors for FI were similar for rural and 
regional participants. Rural participants reported poorer 
general health than regional participants (p=0.004) and lower 
QOL with regard to lifestyle (p=0.028, Table 3). Rural 
participants also presented with more severe FI than regional 
participants (CCF-FI, Table 3), significantly so for males 
(p=0.044). 
 
Participants who failed to complete treatment 
 
Sixty-nine participants completed all 5 treatment sessions 
(median duration 8 weeks). Three patients (all regional) 
failed to attend the final session: one with minimal FI (CCF-
FI=1 and FIQL=4 for each scale) advised he had acquired 
sufficient skills in the first 4 sessions and did not need to 
continue; a second suffered post-surgery bowel dysfunction 
(following treatment for diverticulitis) and found the 
exercises exacerbated the pain and was not prepared to 
continue; the third did not provide a reason, but at the 2 year 
follow up requested further sessions with the biofeedback 
therapist. 
 
Results at completion of treatment 
 
Between the initial and final treatment sessions there were 
significant reductions in incontinent episodes (median of 
4[1–11.5] to 1[0–2.3] per week, p<0.001) and stool 
frequency (median of 13[8–28] to 12[8–20] bowel motions 
per week, p=0.007) as recorded in participants’ bowel 
charts. The CCF-FI reduced significantly (11.5 to 5.0, 
p<0.001) with 86% (59/69) of participants reporting 
improved continence. The FIQL subscales improved 
significantly (Lifestyle, 3.4 to 3.8; Coping, 2.3 to 3.1; 
Depression, 2.8 to 3.4; Embarrassment, 2.2 to 3.3; all 
p<0.001). There was also a significant improvement in the 
patients’ subjective measures of their bowel control over the 
period of treatment, from a median of 3.0/10 (1.8–4) to a 
median of 7.5/10 (6.3–8.6), p<0.001, (0=worst, 
10=best). Objective anorectal manometry and 
proctometrographic measures, undertaken at baseline and at 
the final biofeedback session were significantly improved for 
maximum squeeze pressure (median: 59.2–67.3 mmHg, 
p<0.001) and volume of initial sensation (median: 28–
20 mL, p=0.027); marginally different for mean resting 
pressures (median: 34.6–32.0, p=ns [not significant]); and 
reduced for volume at first urge (median: 73.5–60 mL, p=ns) 
and maximum tolerable volume (150–125 mL, 
p=0.023). There were no significant differences in any 
objective measure between rural and regional participants 
(Table 4). Participants were very satisfied with the treatment 
program, with their median rating being 9 (7.5–10) out of a 
maximum of 10. They also rated individual components of 
the program from very to extremely helpful (Fig3). 
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Table 1:  Participants’ ages according to sex and location 
 
Age (years) 
(95% CI) 
Male Female Total 
Participant 
location 
n Mean n Mean P-value
†
 
n Mean 
Regional 14 67.6 (49-86) 39 60.9 (36-85) 0.044* 53 62.7 (39-86) 
Rural 5 64.2 (44-84) 14 59.2 (32-85) 0.411 19 60.5 (35-86) 
Total 19 66.7 (48-85) 53 60.5 (35-85) 0.029* 72 62.1 (38-86) 
†P value comparing age by sex for rural and regional participants measured using the Wilcoxon unpaired test. 
*P value significant. 
 
 
Table 2:  Participants’ duration of faecal incontinence according to sex and location 
 
Sex 
Median (IQR) 
Male Female Total 
Participant 
location 
n FI Duration
†
 
n FI Duration
†
 
P-value¶ n FI Duration
†
 
Regional 14 24 (13-39) 39 24 (18-60) 0.355 53 24 (17-52) 
Rural 5 36 (25-96) 14 18 (13-27) 0.034* 19 24 (18-36) 
Total 19 24 (15-48) 53 24 (18-52) 0.832 72 24 (18-48) 
FI, Faecal incontinence. 
†Duration in months; ¶p value comparing duration of faecal incontinence by sex for rural and  
regional participants measured using the Wilcoxon  unpaired test. 
*P value significant. 
 
 
While improvement in rural participants’ FIQL and CCF-FI 
scores over the course of treatment had been marginally 
better than that of regional participants, there were no 
significant differences in subjective or objective treatment 
outcomes between regional or rural participants at the final 
treatment session. 
 
Final interview 
 
At the session five interviews at least a quarter of 
participants (33% rural, 25% regional) reported they had 
sought help for their bowel leakage as soon as it occurred, 
while more than a third (45% rural, 40% regional) had 
sought help within 12 months. However, more than a quarter 
of participants (22% rural, 35% regional) did not seek help 
for more than a year. The reasons patients gave for the delay 
in obtaining treatment included: believing the problem 
would go away (26 patients, 6 rural); being too embarrassed 
to seek help (11 patients, 2 rural); being given poor advice 
by a GP, for example that nothing could be done, or that it 
was a normal problem after a 10lb baby (11 patients, 
3 rural); just coping with the problem (13 patients, 2 rural); 
thinking FI was a normal part of aging (6 patients, 2 rural); 
believing they were the only one with the problem and not 
knowing it was treatable (5 patients, 2 rural); and 
experiencing previous unsuccessful treatments such 
as medication, anal stretching or fistula operations (11 
patients, 5 rural).  
 
More than 83% of the participants (15 rural, 45 regional) 
sought initial help from their GP, 4% (2 rural, 1 regional) 
from hospital doctors and 7% (2 rural, 3 regional) from their 
colorectal surgeon. Over 91% were directly referred to the 
colorectal surgeon; the remainder had colonoscopy or other 
investigations before referral to the colorectal surgeon.  
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Table 3:  Quality of life and faecal incontinence severity over study period, according to location13,19 
 
Location Initial session (S1) P Final Session (S5) P 2 Year follow up P 
 n Median (IQR) S1† n Median (IQR) (S1/S5)¶ Improvement 
compared1 
n Median 
(IQR) 
(S1/2Yr)¶ Improvement 
compared
†
 
FIQL: Lifestyle scale 
Regional 53 3.50 (2.9-3.9) 50 3.80 (3.4-4.0) <0.001* 44 3.90 (3.5-4.0) 0.004* 0.481 
Rural 19 3.20 (1.7-3.6) 0.028* 19 3.45 (3.0-3.9) 0.002* 0.523 11 3.30 (2.4-4.0) 0.033*  
FIQL: Coping/behaviour scale 
Regional 53 2.36 (1.5-2.8) 50 3.19 (2.6-3.6) <0.001* 44 3.39 (2.7-4.0) <0.001* 0.423 
Rural 19 2.25 (1.2-2.7) 0.439 19 2.94 (2.3-3.5) <0.001* 0.572 11 2.56 (1.7-4.0) 0.074  
FIQL:  Depression/Self perception scale 
Regional 53 2.89 (2.3-3.6) 50 3.39 (3.2-3.7) <0.001* 44 3.60 (3.1-3.8) <0.001* 0.109 
Rural 19 2.47 (2.2-3.4) 0.130 19 3.39 (2.8-3.6) <0.001* 0.742 11 2.76 (2.2-3.8) 0.424  
FIQL: Embarrassment scale 
Regional 53 2.33 (1.7-3.0) 50 3.33 (3.0-3.7) <0.001* 44 3.67 (2.8-4.0) <0.001* 0.043* 
Rural 19 2.00 (1.3-2.7) 0.100 19 3.33 (2.3-4.0) 0.001* 0.725 11 2.67 (1.7-4.0) 0.108 
 
CCF-FI 
Regional 53 11.0(7.5-14.0) 50 4.5(2.0-8.0) <0.001* 43 3.0(1.0-8.0) <0.001* 0.726 
Rural 19 13.5(9.3-15.8) 0.194 19 5.0(3.0-8.0) <0.001* 0.353 11 8.0(1.0-13.0) 0.059  
CCF-FI, Cleveland Clinic Florida Fecal Incontinence Score; FIQL, Fecal Incontinence Quality of Life Scale; IQR, inter-quartile range; n, number of patients who 
completed questionnaires;  
†Mann-Whitney unpaired test; ¶Outcome compared with baseline, Wilcoxon signed ranks test. 
FIQL: Rockwood et al 2000 [13]; scales calculated as per Rockwood 2008 [19].  
*P value significant.
 
 
 
Table 4:  Anorectal physiology pre- and post-treatment, according to location 
 
Treatment stage 
Initial Session Final Session 
Improvement Assessment criteria 
n Median (IQR) P† n Median (IQR) P¶ P§ 
Mean Resting Pressure (mmHg) 72 34.6 (22-49)  68 32.0 (21-53)  0.071  
Regional 53 34.6 (22-49) 49 31.6 (22-49) 0.055 
Rural 19 34.6 (18-54) 0.919 19 44.8 (18-55) 0.956 0.879 0.226 
Mean Squeeze Pressure (mmHg) 72 59.2 (38-90)  68 67.3 (46-111)  <0.001*  
Regional 53 57.3 (38-80) 49 64.0 (44-101) 0.001* 
Rural 19 76.5 (32-128) 0.220 19 97.8 (49-127) 0.204 0.039* 0.743 
Volume of initial sensation (mL) 72 28.0 (18-40)  64 20.0 (15-30)  0.027*  
Regional 53 25.0 (18-38) 47 20.0 (15-30) 0.055 
Rural 19 35.0 (18-45) 0.547 17 25.0 (15-38) 0.754 0.365 0.778 
Volume of first urge (mL) 72 73.5 (55-100)  63 60.0 (50-85)  0.058  
Regional 53 70.0 (50-103) 46 60.0 (50-85) 0.123 
Rural 19 75.0 (60-100) 0.252 17 80.0 (48-98) 0.592 0.287 0.895 
Max tolerable volume (mL) 71 150 (110-180)  64 125.0 (96-165)  0.023*  
Regional 53 145.0 (108-180) 47 120.0 (95-160) 0.087 
Rural 19 155.0 (139-193) 0.360 17 140.0 (105-178) 0.300 0.109 0.837 
†Baseline regional vs rural participants, Mann Whitney Unpaired test; ¶Completion: regional vs rural participants; Mann Whitney 
unpaired test; §Baseline vs completion: Wilcoxon signed ranks test; improvement: regional vs rural participants; Mann Whitney 
unpaired test. 
*P value significant. 
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Patient rating of treatment components
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Figure 3:  Participant rating of treatment components. 
 
 
All participants attending the final session reported that they 
would advise a friend in a similar situation not to wait, but 
seek help immediately, with 53% specifically citing the 
biofeedback program, 14% their GP and 2% their specialist. 
 
When asked for recommendations to facilitate patient 
disclosure of FI to doctors, suggestions included: asking 
patients directly about FI (54%: 14/19 rural; 22/48 regional, 
p=0.039); listening to patients (39%: 10/19 rural; 
16/48 regional); exhibiting empathy (24%: 8/19 rural; 
8/48 regional, p=0.028); providing advice about FI risk 
factors (24%, 6/19 rural; 11/48 regional); recommending 
biofeedback (18%: 2/19 rural; 11/48 regional); surveying 
patients (7%); shortening biofeedback waitlists (6%); 
providing private FI treatment facilities (6%); GP referral to 
specialist (4%); and more education about available 
treatment for FI for GPs and hospital doctors (12%: 
4/19 rural; 4/48 regional). Patients were asked 'Would a 
confidential survey, completed in the waiting room that you 
handed straight to the GP aid discussion of this or other 
potentially embarrassing problems?' 86% of those asked 
(15/17 rural; 29/34 regional) said it was a good idea; 5 
patients (1 rural) said they would not use it because they had 
good communication with their GP; one person thought a 
general consultation was too short to deal with an additional 
issue, but it could prompt a future discussion; while another 
would prefer to fill it in at home for use at a subsequent 
consultation. 
 
More than 78% of participants had never seen information 
about FI in the community; those who had seen such 
information cited their pharmacy, community nurse, 
speakers at an older women’s network, or the internet. 
 
Over 97% of patients reported that the biofeedback program 
was very/extremely helpful. Five patients mentioned they 
were confident doing their exercises in the clinic with 
biofeedback, but were concerned that they were not doing 
them correctly at home. Of the 49 who were asked if they 
would be interested in trialling a home biofeedback device 
(with an anal sensor), 44 said they would because it would 
‘be motivating’; ‘be good to see an improvement’; or 
Extremely helpful
Very helpful 
A little helpful 
Not helpful 
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confirm they were doing the exercises correctly. Other 
qualitative feedback supported the satisfaction scores. 
 
Two year follow up  
 
Fifty-nine participants (12 rural) responded to the 
February 2008 survey. Thirteen participants were lost to 
follow up; three were deceased (1 rural) and ten (6 rural) 
could not be contacted. For regional participants FIQL and 
CCF-FI scores continued to improve (Table 3), although 
these results were not significantly different from their final 
treatment session, with 44% (19/43) reporting no faecal 
leakage. In contrast rural participants’ FIQL scores had 
declined over time, and with the exception of the FIQL 
lifestyle scale (p=0.033) they were not significantly better 
than the pre-treatment scores (Table 3). For responding rural 
women, improvement in FI severity was maintained at the 
2 year follow up; however, the three rural men who 
answered FI severity questions had reverted to pre-treatment 
levels. Only 18% (2/11) of rural respondents reported no 
faecal leakage. Of the 33 patients (9 rural) who reported still 
having some faecal leakage 14 (2 rural) reported mostly 
staining, 14 (6 rural) reported moderate faecal losses and 1 
(regional) reported loss of a large amount of stool. There 
were no significant differences in results during the 
treatment program between the rural patients who responded 
to the 2 year questionnaire and those who did not. 
 
Since completion of the biofeedback therapy, five survey 
respondents had sought additional help for their FI. New 
treatments included silicone anal implants (1 rural, 
1 regional), stoma (2 rural) and additional medication 
(1 rural). Eleven participants (1 rural) requested further 
biofeedback sessions.  
 
There were no significant differences between rural and 
regional participants in the number of exercises they 
performed or their confidence in performing these exercises, 
although rural participants performed their exercises more 
frequently. Additionally, stool type for rural participants was 
looser (p=0.033), they reduced food intake before going out 
(p=0.005), avoided travelling (p=0.045) particularly by 
aeroplane or train (p=0.002), and had more faecal urgency 
(p=0.048) and avoided visiting friends marginally more often 
(p=0.033). When asked directly, they reported feeling more 
depressed (p=0.048), felt less healthy (p=0.015), enjoyed life 
less (p=0.031), were more afraid to have sex (p=0.031), and 
were more likely to avoid going out to eat (p=0.001). 
 
Discussion 
 
The major findings of this study were that the biofeedback 
treatment program significantly improved continence and 
QOL for both regional and rural participants. While FI 
severity and QOL had continued to improve in regional 
participants 2 years later, for rural participants FI severity 
and QOL had regressed to pre-treatment levels. 
 
Many people enjoy living in rural locations due to higher 
general wellbeing, personal safety and community 
connection20. Rural participants reported poorer general 
health than regional participants prior to treatment, which 
has been previously described in rural populations21. Poorer 
rural health has been linked to lower levels of education, 
employment and income, occupational risks, higher levels of 
hypertension, high cholesterol, asthma, diabetes and risky 
behaviour such as smoking and alcohol abuse, reduced 
access to health services, and driving long distances21,22. 
 
Rural female participants sought help earlier than regional 
women despite their FI severity scores not being 
significantly different. This is possibly due to the greater 
inconvenience to their lifestyle which involves more 
planning and the need to travel further, with less access to 
toilets. In comparison with regional participants, rural 
participants avoided travelling, going out to eat, visiting 
friends, were more afraid to have sex, were more depressed 
and enjoyed life less, all of which could explain their 
reduced sense of wellbeing. 
 
While significant improvement of FI severity and QOL in 
both rural and regional participants was achieved during 
treatment, the QOL of rural participants failed to be 
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maintained over time. As there was no difference in exercise 
maintenance at the 2 year follow up, poorer rural QOL could 
be due to other reasons, such as a change in diet, reduced 
social interaction or lower tolerance of the impact of FI on 
QOL. Rural diet tends to be very different from urban diet, 
including more meat, biscuits and cakes23. Thus the dietary 
changes rural individuals needed to make may have been 
more difficult to maintain over the long term in their rural 
setting. Further research is required to investigate this issue. 
 
Men and women who reside in rural northern Queensland 
may be required to perform heavy physical work (eg farmers 
and cane growers). Heavy lifting has been shown to put 
stress on pelvic floor muscles24 which may in turn contribute 
to FI25. Additionally, in the long term, regular heavy physical 
work or the long working hours of primary producers may 
reduce the likelihood of performing prescribed exercises at 
the end of a tiring day, compared with people in more 
sedentary professions who can perform them at any time26. 
 
Disclosure of taboo subjects can be seen as socially risky, 
and people are less likely to disclose embarrassing 
information, particularly to close friends, relatives or 
respected associates such as GPs27, especially if they believe 
the consequences will be negative6,28. By not admitting an 
urgent need to access toilet facilities to prevent bowel 
leakage, rural participants’ social or informal support 
networks may fail22. To maintain post-treatment QOL 
improvements, rural participants may require referral to a 
counsellor at the end of biofeedback treatment, or longer 
term biofeedback clinic support by way of a home 
biofeedback device, a telephone helpline, newsletter, or 
webpage. 
 
Participants reported that disclosure of FI to their doctor was 
embarrassing and many delayed seeking help. Most thought 
that an ‘embarrassing topic survey tool’ available in their 
GP’s surgery may have assisted them to disclose their FI 
earlier, or the GP to ask patients with risk factors whether 
they had FI, directly and with empathy. They felt this would 
enable disclosure and facilitate treatment, while maintaining 
the professional doctor–patient relationship. An 
embarrassing topic survey tool is currently being assessed. 
 
The short treatment program (5 x 1.5 hour sessions over 
8 weeks), which is comparable with other biofeedback 
programs7,29, may not be sufficiently supportive for rural 
patients in the long term. A similar program in Sydney, 
Australia with 5 monthly sessions, used telephone assisted 
support between initial and final face-to-face sessions for 
rural/remote patients and found no difference in results 
between that method and full clinic attendance for regional 
participants12. The treatment duration of that study was twice 
the length of this study, even though the number of sessions 
was equivalent. Advantages of the longer treatment duration 
may include greater time for patients to practise techniques 
learnt, greater opportunity to present problems to the 
therapist and for the therapist to customise 
treatment. However this may be at the cost of building a 
strong therapist–client relationship, patient focus and 
motivation in the short term.  
 
Conclusion  
 
For rural participants to maintain similar long-term 
improvement in continence and QOL to regional 
participants, an additional follow-up session with the 
biofeedback therapist and ongoing local support by 
continence advisors should be investigated for these patients. 
A telephone helpline, newsletter, or webpage may also be 
beneficial. 
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